Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens. [electronic resource]
Producer: 20100107Description: 33-7 p. digitalISSN:- 1532-4192
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bevacizumab
- Camptothecin -- administration & dosage
- Chemotherapy, Adjuvant
- Colorectal Neoplasms -- drug therapy
- Disease Progression
- Female
- Humans
- Irinotecan
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Retrospective Studies
- Time Factors
- Treatment Failure
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.